1 / 56

GANGGUAN PUBERTAS

GANGGUAN PUBERTAS. Dr Eka Agustia Rini Sp AK Sub Bagian Endokrinologi Ilmu Kesehatan Anak FK-UNAND / RS Dr M. Djamil Padang. PRECOCIOUS PUBERTY. Hypothalamus - Pituitary – Gonad axis. INTRODUCTION. Epidemiology Frequency : girls > boys Girls: most have a benign central cause

auberta
Télécharger la présentation

GANGGUAN PUBERTAS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GANGGUAN PUBERTAS Dr Eka Agustia Rini Sp AK Sub Bagian Endokrinologi Ilmu Kesehatan Anak FK-UNAND / RS Dr M. Djamil Padang

  2. PRECOCIOUS PUBERTY

  3. Hypothalamus - Pituitary – Gonad axis

  4. INTRODUCTION • Epidemiology • Frequency : girls > boys • Girls: most have a benign central cause • Boys: 50% pathologic peripheral cause.  all boys with precocious puberty should undergo detailed investigation, but in girls additional investigation can be based on the clinical impression

  5. Precocious Puberty • Definition • Appearance of secondary sexual characteristics : boys < 9 years and girls < 8 years old (- 2SD) • Sex steroid  • Estrogen: female • Testosterone:male

  6. Effect of sex steroid • Estrogen • Accelerated bone maturation and early epiphyseal fusion (tall child but short adult) • Uterus, mammary gland • Testosterone • Genital, Hirsutism, acne, male habitus • General:sexual behavior, aggressiveness

  7. Classification • GnRH dependent (central) : • premature reactivation hypothalamus-pituitary-gonad axis  increased gonadotropin  increased sex steroids (dependent) • Usually idiopathic • GnRH independent (peripheral): • autonomous sex steroid secretion,  depressing the hypothalamus-pituitary-gonad axis • Usually pathologic

  8. Classification • Variant • premature thelarche • premature adrenarche • gynecomastia

  9. Etiology GDPP • idiopathic • CNS • tumor • non-tumor: post infection, radiation, trauma, congenital • iatrogenic • Delayed diagnosis of GIPP

  10. Clinical manifestation GDPP • Always isosexual • Normal sequence of puberty • Hormonal profile: increased gonadotropin and sex steroid

  11. Etiology GIPP - male • Isosexual • adrenal: tumor, CAH • testes : cell Leydig tumor, familial testotoxicosis • gonadotropin-secreting tumor: • non CNS: hepatoma, germinoma, teratoma • CNS: germinoma, adenoma (LH secreting) • heterosexual • Increased peripheral aromatization

  12. Etiology GIPP - female • Isosexual) • McCune Albright • Severe hypothyroid • heterosexual • adrenal: tumor, CAH • tumor ovarium: arrhenoblastoma

  13. Mc Cune Albright Syndrome • Trias • Precocious puberty / endocrine hyperactivity • Fibrodysplasia • Café au lait

  14. Clinical manifestation GIPP • Isosexual or heterosexual (late onset CAH, tumor adrenal) • Disconcordant of sexual characteristics (testes volume inappropriate with pubertal stage - smaller) • Low or normal gonadotropin and increased sex steroid

  15. Benign Premature Adrenarche • self-limited condition occurring before six years of age • characterized by the appearance of pubic and no further secondary sexual development. • normal growth patterns

  16. Benign Premature Adrenarche • Normal bone age • Slight elevation of serum DHEA • Normal adrenal steroid hormone levels • Normal sex hormone levels • ACTH stimulation test: to exclude late-onset CAH • GnRH test: prepubertal pattern • Normal imaging studies • No specific treatment required

  17. Premature Adrenarche • Excude virilization • clitoral enlargement, advanced bone age, acne, rapid growth, and voice change. • rapid progression • If virilization present • measure testosterone, 17-OHP and DHEA • USG: adrenal or ovarian tumor • 17-OHP or DHEA: CAH

  18. Benign Premature Thelarche • Isolated appearance of unilateral or bilateral breast aged 6 months to 3 years • No other signs of puberty or evidence of excessive estrogen effect (thickening of the vaginal secretions or bone age acceleration). • Ingestion or application of estrogen-containing compounds must be excluded as etiology

  19. Benign Premature Thelarche • Normal growth rate and bone age • Normal levels of gonadotropins and estradiol • USG: normal ovaries, prepubertal uterus • Usually resolves spontaneously and requires no treatment • re-evaluation at intervals of 6-12 months to ensure that premaure thelarche is not the beginning of isosexual precocious puberty

  20. Gynecomastia • Breast enlargement in males • common in teenage years, lasting 2 years • differentiate with obese boys • lipomastia • no mammae disk • Pathological causes must be sought

  21. Pubertal Gynecomastia • Incidence: 50-60% of boys during early adolescence • breast tissue usually asymmetric and often tender. • If history and physical examination, including palpation of the testicles, are unremarkable, reassurance and periodic reevaluation are all that is necessary. Most cases resolve in one to two years.

  22. Gynecomastia • Drugs • sex steroids, hCG, psychoactive (phenotiazine), antituberculosis, testosterone antagonist (ketoconazole, cimetidine, spironolactone) • Malnutrition • Idiopathic (most common) • Tumor producing disease • hepatoma, adrenal, testes, LH and hCG producing tumors

  23. Pubertal Gynecomastia • Familial gynecomastia • X-linked recessive trait or a sex-limited dominant trait • unless associated with hypogonadism no further evaluation in an otherwise normal boy • If severe, gynecomastia  cosmetic surgery. • Pathologic gynecomastia • Klinefelter's syndrome: high risk for breast cancer • prolactin-secreting adenomata

  24. Pubertal Gynecomastia • Pathologic gynecomastia • hormone-secreting tumors (testes, hepatoma), cirrhosis, hypo- and hyperthyroidism. • Drug induced (marijuana, phenothiazines, opiates, amphetamines, digitalis, estrogens, ketoconazole, spironolactone, isoniazid, tricyclic antidepressants, cimetidine, etc). • If worsens and associated with psychologic morbidity  bromocriptine, tamoxifen • reduction mammoplasty rarely indicated.

  25. Diagnostic work up • Gonadotropin dependent or independent? • Etiology?

  26. Hypothalamus GnRH (-) Pituitary LH/FSH Gonad E2 or T H-P-G axis

  27. Hypothalamus Primary GnRH (-) Pituitary LH/FSH Gonad Sex steroid  H-P-G axis in GDPP

  28. Hypothalamus GnRH (-) Pituitary LH/FSH Gonad Extra Gonadal PRIMARY Sex steroid  H-P-G axis in GIPP

  29. Diagnostic work up • Historyage of onset, progressivity, family history, growth, symptoms extragonadal cause (adrenal), CNS complaints, gelactic laughter (hamartoma), previous history: encephalitis, meningitis TB • Physical examinationpubertal stage, signs of virilisation, height, testes size (small indicative of perpheral cause), CNS signs, skin (acne, café au lait),

  30. Diagnostic work up • Laboratorygonadotropin, bHCG, 17-OHProgesterone (CAH), cortisol (Cushing syndrome, adrenal tumor) • ImagingBone age, pelvic ultrasound, skull x-ray, CT/MRI, bone survey (McCune Albright),

  31. Therapy • According to the etiology • GDPP idiopathic: GnRH agonis • GIPP : medroxy-progesteron, ketoconazole, dll • Variant: observation

  32. Prognosis • According to etiology • GDPP idiopathic: GnRH agonis • Final height = potential genetic height • Preserved fertility • Psychosocial minimal, regression of secondary sex • GIPP : medical • Potential genetic height  • Regression of secondary sex  

  33. Conclusion • Not all pubertal disorders are pathologic • Early increase of sex steroid should be thoroughly investigated • GnRH agonist = drug of choice for GDPP

  34. DELAYED PUBERTY

  35. Definisi • Pubertas terlambat bila tidak adanya tanda-tanda pubertas • laki-laki pada usia 14 tahun • perempuan pada usia 13 tahun • Klasifikasi • hipergonadotropik hipogonadism • hipogonadotropik hipogonadism • Ammenorrhoe primer • Ammenorrhoe sekunder

  36. hipogonadism Hipergonadotropik Hipotalamus LHRH LH/FSH Hipofisis (-) Target Organ (gonad) Primary defect Sex Steroid

  37. Hipergonadotropik hipogonadism • Dengan kelainan kromosom • Dysgenesis gonad • Sindrom Turner • Pure gonadal dysgenesis • Sindrom Klinefelter • Androgen Insensitivity Syndrome *

  38. Hipergonadotropik hipogonadism • Tanpa kelainan kromosom • kongenital • gangguan biosintesis steroid adrenal (P450c17,P450scc,3bHSD) dan gonad (17-KS, P450 aromatase) • anorchia, ovary resistant syndrome, LH resistance • didapat • radiasi, chemotherapy, proses autoimun

  39. hipogonadism Hipogonadotropik Hipotalamus LHRH Primary defect LH/FSH Hipofisis (-) Target Organ (gonad) Sex Steroid

  40. Hipogonadotropik hipogonadism • Constitutional delay • Kelainan Susunan Syaraf Pusat • Tumor (craniopharyngioma, germinoma, optic glioma, histiocytosis X) • Struktural (mid line defect) • Sindrom Kallmann • hipopituitarism idiopathic • pasca tindakan (radiasi, khemoterapi inflamasi, infiltrasi - hemosiderosis)

  41. Hipogonadotropik hipogonadism • Penyakit kronis • endokrin, malnutrisi/anorexia nervosa, kelainan sistemik • Aktivitas fisik berlebihan • Sindrom-sindrom • Prader-Willi; Laurence-Moon-Biedl

  42. Hypothalamic and pituitary causes of pubertal failure-low gonadotrophins • Congenital defects • Kalmann syndrome • Congenital adrenal hypoplasia • Septoptic dysplasia • Development defect of pituitary • Tumors, direct effects or following radiotherapy or surgery • Haemochromatosis

  43. Italian Working Group on Endocrine Complication in non-endocrine diseases, 1993

  44. Delayed puberty in Thalassamia patient • Italian Multicenter Thalassemia study 1993, (29 centers), 3092 patients : Puberty failure: males 41 % females 39,5 % All patient with hemachromatosis need periodic careful endocrine evaluation

  45. Tatalaksana • Anamnesis • Pemeriksaan fisik • Pemeriksaan penunjang • Terapi

  46. Anamnesis • Riwayat perkembangan pubertas di dalam keluarga • Data pertumbuhan & perkembangan • Riwayat penyakit/pengobatan dahulu • Fungsi penciuman

  47. Pemeriksaan fisik • Pemeriksaan fisik secara umum • Pemeriksaan neurologis (funduskopi) d • Antropometri (TB, BB, rasio segmen atas dan bawah, rentang lengan) • Status pubertas • Stigmata suatu sindrom (pendek, obese, retardasi mental, webbed neck dll)

  48. Pemeriksaan Penunjang • Pencitraan: • usia tulang, CT scan/MRI kepala & USG genitalia interna (atas indikasi), • Hormonal (basal/ uji GnRH) • LH,FSH,Prolactin, Estrogen atau testosterone • Dan lain-lain • analisis kromosom (atas indikasi) • uji fungsi penciuman

More Related